Scientific News Thermo Fisher Scientific Nyse Tmo Has A Pretty Healthy Balance Sheet
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Thermo Fisher Scientific Nyse Tmo Has A Pretty Healthy Balance Sheet is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Morgan Stanley Maintains Thermo Fisher Scientific (TMO) Overweight Recommendation
Fintel reports that on December 2, 2025, Morgan Stanley maintained coverage of Thermo Fisher Scientific (NYSE:TMO) with a Overweight recommendation. Analyst Price Forecast Suggests 6.87% Upside As of ... Read More
Thermo Fisher (TMO) Raises €2.1 Billion Through Floating and Fixed-Rate Senior Notes
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best dividend stocks to buy according to hedge funds. On November 25, Thermo Fisher reported that it had made an offering of euro-dominated notes ... Read More
13 Analysts Assess Thermo Fisher Scientific: What You Need To Know
During the last three months, 13 analysts shared their evaluations of Thermo Fisher Scientific (NYSE:TMO), revealing diverse outlooks from bullish to bearish. Summarizing their recent assessments, the ... Read More
A Preview Of Thermo Fisher Scientific's Earnings
Thermo Fisher Scientific TMO is set to give its latest quarterly earnings report on Wednesday, 2025-07-23. Here's what investors need to know before the announcement. Analysts estimate that Thermo ... Read More
TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth
Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best low volatility stocks to buy according to analysts. On July 16, TD Cowen maintained its Buy rating on Thermo Fisher Scientific Inc. Read More
Thermo Fisher Positioned As Biopharma's Partner Of Choice
Could Thermo Fisher Scientific Inc. (NYSE:TMO) be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven ... Read More
Thermo Fisher Scientific: Recovery In Sight, Attractively Valued
Thermo Fisher has good growth prospects ahead. Core pharma, biotech, and bioproduction businesses are driving growth, with US manufacturing investments and the Solventum acquisition strengthening ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus